Which birth control dose works best for PCOS? new study compares 20µg vs 30µg

NCT ID NCT07318337

Completed Disease control Sponsor: Mst.Sumyara Khatun Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at two different doses of a birth control pill (drospirenone-ethinyl estradiol) in 60 women with PCOS. The goal was to see which dose better lowers a hormone marker called free androgen index. Participants took either a 20µg or 30µg dose daily for 3 months, and their hormone levels were measured before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Drospirenone-ethinyl estradiol (birth control pill)
What this could lead to: If successful, this could help doctors choose the best dose of birth control to manage hormone levels in women with PCOS, potentially reducing side effects.
What could go wrong: This is a small, completed study with only 60 participants, so results may not apply to everyone. The treatment only lasts 3 months, so long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PCOS (POLYCYSTIC OVARY SYNDROME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

polycystic ovary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PCOS (POLYCYSTIC OVARY SYNDROME)

Contacts and locations

Locations

Bangladesh Medical University

Dhaka, 1000, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.